开发一种临床预测模型,用于COPD患者的跌倒情况
Khang Trong Nguyen1, Dina Brooks2,3, Luciana G Macedo2
1Rehabilitation Science, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.
BMJ open respiratory research
|December 25, 2025
概括
预测慢性阻塞性肺病 (COPD) 患者未来的跌倒是非常重要的. 在COPD患者中,多次跌倒的病史,更多的慢性疾病和运动障碍预测了未来的跌倒.
科学领域:
- 老年学是一门学科.
- 肺部病理学 肺部病理学
- 临床预测建模临床预测建模
背景情况:
- 慢性阻塞性肺病 (COPD) 与跌倒的风险增加有关.
- 目前缺乏准确的预测方法来预测COPD患者的跌倒情况.
- 这项研究旨在开发和验证COPD患者中跌倒的临床预测模型.
研究的目的:
- 开发和内部验证一种临床预测模型,用于预测被诊断患有COPD的个人未来的跌倒.
- 确定COPD人口中跌倒的关键预测因素.
主要方法:
- 来自一项防摔试验的数据的二次分析,该试验涉及178名患有COPD的参与者.
- 多变量逻辑回归被用来开发预测模型.
- 内部验证采用引导重新抽样来评估模型歧视 (c-统计) 和校准 (E:O比率,CITL,校准斜率).
主要成果:
- 最终的模型确定了未来12个月跌倒的三个显著预测因素:病史≥2次跌倒,慢性病的数量增加以及在定时和Go双任务测试中的表现较差.
- 预测模型证明了可接受的歧视 (c-统计=0.69) 和校准.
- 74名 (42%) 参与者在12个月的随访期间经历了≥1次跌倒.
结论:
- 在认知需求下,多次跌倒,并发症和运动障碍的病史是COPD患者未来跌倒的重要预测因素.
- 开发的临床预测模型显示可接受的内部有效性.
- 建议进行外部验证,以确认这些发现的概括性.
相关概念视频
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K
COPD: Management Using Bronchodilators and Corticosteroids
698
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
698


